D-chiro-inositol and Endometrial Thickness

NCT05283642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2022-12-23

No results posted yet for this study

Summary

Investigation of the effects of D-chiro-inositol supplementation in women with altered endometrial thickness.

Conditions

  • Endometrial Diseases

Interventions

DIETARY_SUPPLEMENT

DCI

Oral supplementation with D-chiro-inositol once daily

Sponsors & Collaborators

  • Lo.Li.Pharma s.r.l

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-08
Primary Completion
2022-10-29
Completion
2022-12-20

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05283642 on ClinicalTrials.gov